Pacira Biosciences, Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K Current Report was filed by Pacira Pharmaceuticals, Inc. (now Pacira Biosciences, Inc.) on March 13, 2013. The filing discloses the entry into material definitive agreements regarding real estate leases and amendments to executive employment contracts.
Key Financial Metrics and Agreements
The filing details two lease amendments and executive compensation adjustments. No revenue, profit, or cash flow data is provided in this specific report.
- San Diego Lease (Third Amendment): Extends term to August 31, 2020, with a five-year option. Monthly rent ranges from $278,381.40 (2013) to $342,374.01 (2020). Includes a $1,265,370 tenant improvement allowance, with potential increases up to $3,679,740 total if specific conditions are met.
- La Jolla Lease (Fifth Amendment): Extends term to August 31, 2020, with a five-year option. Monthly rent ranges from $66,456.60 (2013) to $81,733.24 (2020). Includes a $326,190 tenant improvement allowance, with potential increases up to $978,570 total.
- Executive Severance: Amendments modify severance for five officers (David Stack, Taunia Markvicka, James Scibetta, John Pratt, Lauren Riker) in the event of termination without cause or for good reason near a change of control.
Material Changes and Compensation Details
The primary material changes involve the extension of lease terms and the enhancement of severance packages for key executives.
- David Stack: Entitled to 24 months of base salary and a lump-sum bonus equal to 100% of base salary upon qualifying termination.
- Taunia Markvicka, James Scibetta, John Pratt: Entitled to 12 months of base salary and a lump-sum bonus equal to 30% of base salary.
- Lauren Riker: Entitled to 12 months of base salary and a lump-sum bonus equal to 25% of base salary.
- Common Provisions: All officers receive 12 months of COBRA premium coverage. Existing provisions for 100% acceleration of unvested option shares upon change of control remain unchanged.
Outlook, Risks, and Contingencies
The filing does not provide forward-looking financial guidance or management commentary on business outlook. Key contingencies include:
- Lease Options: The right to extend leases for an additional five years is contingent upon written notice between 9 and 12 months prior to the current expiration and satisfaction of lease conditions.
- Allowance Expiration: Unused tenant improvement allowances for both properties will revert to the landlords if not utilized by June 30, 2015.
- Rent Adjustments: Exercising additional allowance options prior to October 1, 2013, will result in increased monthly basic rent to repay the landlord.
Investor Verification Checklist
- Verify the total potential capital expenditure impact of the tenant improvement allowances ($4.66M max potential across both sites).
- Confirm the impact of increased monthly rent obligations if the "Additional Allowance" options are exercised.
- Review the specific definitions of "termination without cause" and "good reason" in the attached employment agreements to assess the likelihood of severance payouts.
- Monitor the June 30, 2015 deadline for utilizing tenant improvement funds to avoid forfeiture.